0001127602-14-010717.txt : 20140307
0001127602-14-010717.hdr.sgml : 20140307
20140307161700
ACCESSION NUMBER: 0001127602-14-010717
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140306
FILED AS OF DATE: 20140307
DATE AS OF CHANGE: 20140307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
BUSINESS PHONE: 2054444600
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEE KENNETH B JR
CENTRAL INDEX KEY: 0001208570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 14677448
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-03-06
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001208570
LEE KENNETH B JR
4505 EMPEROR BLVD., SUITE 200
DURHAM
NC
27703
1
Common Stock
2014-03-06
4
M
0
22917
3.80
A
22917
D
Common Stock
2014-03-06
4
S
0
12665
12.69
D
10252
D
Non-Qualified Stock Option
3.80
2014-03-06
4
M
0
22917
0
D
2011-06-30
2021-06-27
Common Stock
22917
0
D
Shares of Common Stock sold to satisfy payment of exercise price, taxes, and related broker fees and commissions for stock option exercise.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.60 to $12.75. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2014-03-07